MarketInOut Stock Screener Log In | Sign Up

NGL Fine-Chem Ltd

Healthcare • Drug Manufacturers - General • Quote as of 10/28/2026 15:50
NGL Fine-Chem Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
Market Capitalization16,408 mln
Float1.68 mln

EPS

92.59
Exceptional

P / E

28.20
Elevated

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.24
Borderline

Relative Strength

24 / 100
Significantly lagging

Debt / Equity

0.37
Low leverage

Business Description

Founded in 1981 and headquartered in Mumbai, India, NGL Fine-Chem Limited produces active pharmaceutical ingredients, specialty chemicals, and finished medicines for both animal and human health markets. The company serves customers across India, Europe, the Asia Pacific region, and the United States. Its product range covers a broad spectrum of treatments for livestock and companion animals, alongside select human health ingredients and chemical intermediates.

Key Fundamentals

EPS92.59
P/E28.20
ROE18.82
RPS867
ROIC12.96
ROA11.72
Interest Cover15.04
EBITDA, mln1,007
EV / EBITDA18.42
EV / EBIT23.15
Revenue, mln5,362
EV / Revenue3.46

Quote Details

Last 2,610.60
Change -21.9 (-0.83%)
Open 2,614.50
Volume 2,655
Turnover 6,931,144
Average Volume 10,076

Financial Ratios

Pre-Tax Profit Margin14
Current Ratio1.84
Price / Book5.47
Price / Tangible Book5.48
Price / Cash Flow97.83
Debt / Equity0.37
Price / Sales3.35

Financial Strength

Altman Z-Score7.51
Piotroski F-Score 6 / 9
Beneish M-Score-2.24
Price to Graham Number3.02
Shiller PE Ratio47.97

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.49% 60 / 100   
1 Month -10.17% 37 / 100   
2 Months -19.31% 21 / 100   
6 Months 12.72% 77 / 100   
1 Year 72.15% 94 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog